| http://www.w3.org/ns/prov#value | - Agent: Tarolli, Sundheim, Covell & Tummino L.L.P.20090312316 - Novel compounds: The present invention relates to derivatives of borrelidin that are useful in medicine, e.g. in the treatment of cancer or B-cell malignancies, or other diseases in which angiogenesis contributes to the pathology including ophthalmic disorders such as diabetic retinopathy as well as age related macular degeneration (AM
|
